Search

everythinglearnresearchcommunity

for

Search:↓

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Current treatments for alopecia show no significant long-term benefits.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Careful planning and technique are crucial for successful hair transplants on irradiated scalps.

Some drugs used to treat immune conditions may cause different types of hair loss.

A 76-year-old man's grey hair turned back to its original color after radiotherapy.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Hair transplant surgery may cause alopecia areata, a new possible complication.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

Topical minoxidil, intralesional steroids, and cryotherapy significantly improve alopecia areata.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Alopecia areata might help slow down certain cancers.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.